Treatment Information

Back

Lung Cancer treatment details. Chemotherapy, Radiation.

University of Pittsburgh Cancer Institute, Pittsburgh, PA, United States.

Survival: monthsCountry:United States
Toxiciy Grade:5City/State/Province:Pittsburgh, PA
Treatments:Chemotherapy, RadiationHospital:University of Pittsburgh Cancer Institute
Drugs:Journal:Link
Date:Sep 2005

Description:

Patients: This Phase II/III study involved 276 patients with advanced non-small-cell lung cancer who were randomly assigned into three groups. Group B had 74 patients (54 men, 20 women); twenty-one patients were over 70 years old.

Treatment: The treatment consisted of radiotherapy and two chemotherapeutic agents: carboplatin and paclitaxel. Group B received induction chemotherapy followed by both chemotherapy and radiotherapy.

Toxicity: There was one treatment related death in this group from infection. Other Chemotherapeutic toxicities included: grade 3-4 granulocytopenia, leukopenia, nausea/vomiting, and hyperglycemia. Radiotherapeutic toxicities for Group B included: leukopenia, esophagitis, granulocytopenia, thrombocytopenia, nausea/vomiting, neurologic, and anemia.

Results: The median overall survival for this group was 12.7 months.

Support: Bristol Meyers Squibb financially supported this study, and several authors have disclosed financial relationships with Bristol Meyers Squibb. Bristol Meyers Squibb manufactures and/or markets paclitaxel and carboplatin.

Correspondence: Chandra P. Belani, MD




Back